Loss of E-cadherin-mediated cell contacts reduces estrogen receptor alpha (ERα) transcriptional efficiency by affecting the respective contribution exerted by AF1 and AF2 transactivation functions

Biochemical and Biophysical Research Communications

Volumn 365, Issue 2, 2008, Pages 304-309

  Huet, Guillaume ^a   Mérot, Yohann ^a   Le Dily, François ^a   Kern, Laurence ^a   Ferrière, François ^a   Saligaut, Christian ^a   Boujrad, Noureddine ^a   Pakdel, Farzad ^a   Métivier, Raphaël ^a   Flouriot, Gilles ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Cell cell junctions; E cadherins; Epithelial mesenchymal transition (EMT); Estrogen receptor alpha; Transactivation functions

Indexed keywords

ESTROGEN RECEPTOR ALPHA; UVOMORULIN;

ARTICLE; CELL CONTACT; CELL DIFFERENTIATION; CELL JUNCTION; CELL LINE; EPITHELIUM CELL; ESTROGEN ACTIVITY; MESENCHYME; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; UPREGULATION;

CADHERINS; CELL LINE; ESTROGEN RECEPTOR ALPHA; FURYLFURAMIDE; HELA CELLS; HEPATOCYTES; HUMANS; INTERCELLULAR JUNCTIONS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 36248998311     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.178     Document Type: Article

References (28)

1. Green S., Walter P., Kumar V., Krust A., Bornert J.M., Argos P., and Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320 (1986) 134-139
2. Hewitt S.C., Harrell J.C., and Korach K.S. Lessons in estrogen biology from knockout and transgenic animals. Annu. Rev. Physiol. 67 (2005) 285-308
3. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., and Gustafsson J.A. Mechanisms of estrogen action. Physiol. Rev. 81 (2001) 1535-1565
4. Deroo B.J., and Korach K.S. Estrogen receptors and human disease. J. Clin. Invest. 116 (2006) 561-570
5. Platet N., Cathiard A.M., Gleizes M., and Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit. Rev. Oncol. Hematol. 51 (2004) 55-67
6. Hall J.M., and McDonnell D.P. Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting. Mol. Interv. 5 (2005) 343-357
7. Metzger D., Ali S., Bornert J.M., and Chambon P. Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J. Biol. Chem. 270 (1995) 9535-9542
8. McInerney E.M., and Katzenellenbogen B.S. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. J. Biol. Chem. 271 (1996) 24172-24178
9. Metivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., and Gannon F. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115 (2003) 751-763
10. Fowler A.M., and Alarid E.T. Nuclear receptor and transcriptional complex cycles. Sci STKE 2004 (2004) tr11
11. Kobayashi Y., Kitamoto T., Masuhiro Y., Watanabe M., Kase T., Metzger D., Yanagisawa J., and Kato S. p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains. J. Biol. Chem. 275 (2000) 15645-15651
12. Metivier R., Penot G., Flouriot G., and Pakdel F. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains. Mol. Endocrinol. 15 (2001) 1953-1970
13. Tora L., White J., Brou C., Tasset D., Webster N., Scheer E., and Chambon P. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59 (1989) 477-487
14. Tzukerman M.T., Esty A., Santiso-Mere D., Danielian P., Parker M.G., Stein R.B., Pike J.W., and McDonnell D.P. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8 (1994) 21-30
15. Berry M., Metzger D., and Chambon P. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9 (1990) 2811-2818
16. McDonnell D.P., and Norris J.D. Connections and regulation of the human estrogen receptor. Science 296 (2002) 1642-1644
17. Merot Y., Metivier R., Penot G., Manu D., Saligaut C., Gannon F., Pakdel F., Kah O., and Flouriot G. The relative contribution exerted by AF-1 and AF-2 transactivation functions in estrogen receptor alpha transcriptional activity depends upon the differentiation stage of the cell. J. Biol. Chem. 279 (2004) 26184-26191
18. Jiang W.G., and Mansel R.E. E-cadherin complex and its abnormalities in human breast cancer. Surg. Oncol. 9 (2000) 151-171
19. Thiery J.P. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 15 (2003) 740-746
20. Penot G., Le Peron C., Merot Y., Grimaud-Fanouillere E., Ferriere F., Boujrad N., Kah O., Saligaut C., Ducouret B., Metivier R., and Flouriot G. The human estrogen receptor-alpha isoform hERalpha46 antagonizes the proliferative influence of hERalpha66 in MCF7 breast cancer cells. Endocrinology 146 (2005) 5474-5484
21. Metivier R., Petit F.G., Valotaire Y., and Pakdel F. Function of N-terminal transactivation domain of the estrogen receptor requires a potential alpha-helical structure and is negatively regulated by the A domain. Mol. Endocrinol. 14 (2000) 1849-1871
22. Tetel M.J., Giangrande P.H., Leonhardt S.A., McDonnell D.P., and Edwards D.P. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Mol. Endocrinol. 13 (1999) 910-924
23. Lonard D.M., and O'Malley B.W. Expanding functional diversity of the coactivators. Trends Biochem. Sci. 30 (2005) 126-132
24. Xu W. Nuclear receptor coactivators: the key to unlock chromatin. Biochem. Cell Biol. 83 (2005) 418-428
25. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., and Nieto M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2 (2000) 76-83
26. Fujita N., Jaye D.L., Kajita M., Geigerman C., Moreno C.S., and Wade P.A. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113 (2003) 207-219
27. Pietras R.J., Arboleda J., Reese D.M., Wongvipat N., Pegram M.D., Ramos L., Gorman C.M., Parker M.G., Sliwkowski M.X., and Slamon D.J. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10 (1995) 2435-2446
28. Wright C., Nicholson S., Angus B., Sainsbury J.R., Farndon J., Cairns J., Harris A.L., and Horne C.H. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. Br. J. Cancer 65 (1992) 118-121